跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“AβOs”
全部
72
临床试验
49
药物
5
机构
2
资讯
16
去年
Acumen Pharmaceuticals Advances Sabirnetug in Alzheimer's Disease Treatment
去年
Acumen's ACU193 Shows Promise as First-in-Class Alzheimer's Treatment Targeting Toxic Amyloid Oligomers
去年
Acumen Pharmaceuticals Advances Alzheimer's Pipeline with JCR Partnership and ALTITUDE-AD Phase 2 Trial
去年
ProMIS Neurosciences' PMN310 Shows Promise in Phase 1a Alzheimer's Trial
10个月前
Acumen Pharmaceuticals Initiates Open-Label Extension Study for Alzheimer's Drug Sabirnetug
去年
Acumen Pharmaceuticals Utilizes pTau217 Assay in Sabirnetug Phase 2 Alzheimer's Trial
去年
ProMIS Neurosciences' PMN310 Shows Promise in Phase 1a Alzheimer's Trial
去年
Acumen Pharmaceuticals Partners with JCR to Develop Enhanced Brain Delivery Therapy for Alzheimer's Disease
2年前
ProMIS Reports Positive Phase Ia Trial Results for Alzheimer's Treatment
去年
Acumen and Lonza Expand Collaboration to Advance Sabirnetug for Alzheimer's Disease
第 1 页,共 2 页
上一页
下一页